Cytomegalovirus Evasion of Innate Immunity by Subversion of the NKR-P1B:Clr-b Missing-Self Axis

Immunity

Volumn 26, Issue 5, 2007, Pages 617-627

  Voigt, Sebastian ^a   Mesci, Aruz ^b   Ettinger, Jakob ^a   Fine, Jason H ^b   Chen, Peter ^b   Chou, Wayne ^b   Carlyle, James R ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Sunnybrook Health Sciences Centre   (Canada)

Author keywords

CELLIMMUNO; MICROBIO; MOLIMMUNO

Indexed keywords

C TYPE LECTIN LIKE PROTEIN; CD161 ANTIGEN; CLR B PROTEIN; GENE PRODUCT; NATURAL KILLER CELL RECEPTOR P1B; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL KILLING; CELL PROTECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; RAT; SEQUENCE HOMOLOGY; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENOME, VIRAL; HUMANS; IMMUNITY, NATURAL; LECTINS, C-TYPE; LIGANDS; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; PHYLOGENY; RATS; RECEPTORS, CALCITONIN; RECEPTORS, IMMUNOLOGIC; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VIRUS INTERNALIZATION;

EID: 34248595509     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.03.013     Document Type: Article

References (43)

1. Aldemir H., Prod'homme V., Dumaurier M.J., Retiere C., Poupon G., Cazareth J., Bihl F., and Braud V.M. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 175 (2005) 7791-7795
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
3. Bezouska K., Yuen C.T., O'Brien J., Childs R.A., Chai W., Lawson A.M., Drbal K., Fiserova A., Pospisil M., and Feizi T. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372 (1994) 150-157
4. Brocchieri L., Kledal T.N., Karlin S., and Mocarski E.S. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 79 (2005) 7570-7596
5. Bubic I., Wagner M., Krmpotic A., Saulig T., Kim S., Yokoyama W.M., Jonjic S., and Koszinowski U.H. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78 (2004) 7536-7544
6. Carlyle J.R., Martin A., Mehra A., Attisano L., Tsui F.W., and Zuniga-Pflucker J.C. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J. Immunol. 162 (1999) 5917-5923
7. Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H., and Raulet D.H. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101 (2004) 3527-3532
8. Carlyle J.R., Mesci A., Ljutic B., Belanger S., Tai L.H., Rousselle E., Troke A.D., Proteau M.F., and Makrigiannis A.P. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J. Immunol. 176 (2006) 7511-7524
9. Chambers W.H., Vujanovic N.L., DeLeo A.B., Olszowy M.W., Herberman R.B., and Hiserodt J.C. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169 (1989) 1373-1389
10. Giorda R., Rudert W.A., Vavassori C., Chambers W.H., Hiserodt J.C., and Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science 249 (1990) 1298-1300
11. Glimcher L., Shen F.W., and Cantor H. Identification of a cell-surface antigen selectively expressed on the natural killer cell. J. Exp. Med. 145 (1977) 1-9
12. Hao L., Klein J., and Nei M. Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc. Natl. Acad. Sci. USA 103 (2006) 3192-3197
13. Hargreaves D.C., and Medzhitov R. Innate sensors of microbial infection. J. Clin. Immunol. 25 (2005) 503-510
14. Hassink G.C., Duijvestijn-van Dam J.G., Koppers-Lalic D., van Gaans-van den Brink J., van Leeuwen D., Vink C., Bruggeman C.A., and Wiertz E.J. Rat cytomegalovirus induces a temporal downregulation of major histocompatibility complex class I cell surface expression. Viral Immunol. 18 (2005) 607-615
15. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., and Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4 (2003) 801-807
16. Karre K., Ljunggren H.G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319 (1986) 675-678
17. Keller R., Bachi T., and Okumura K. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody. Exp. Cell Biol. 51 (1983) 158-164
18. Kufer T.A., Fritz J.H., and Philpott D.J. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol. 13 (2005) 381-388
19. Kumar V., and McNerney M.E. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5 (2005) 363-374
20. Kung S.K., Su R.C., Shannon J., and Miller R.G. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J. Immunol. 162 (1999) 5876-5887
21. Kveberg L., Back C.J., Dai K.Z., Inngjerdingen M., Rolstad B., Ryan J.C., Vaage J.T., and Naper C. The novel inhibitory NKR-P1C receptor and Ly49s3 identify two complementary, functionally distinct NK cell subsets in rats. J. Immunol. 176 (2006) 4133-4140
22. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 23 (2005) 225-274
23. Lenac T., Budt M., Arapovic J., Hasan M., Zimmermann A., Simic H., Krmpotic A., Messerle M., Ruzsics Z., Koszinowski U.H., et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203 (2006) 1843-1850
24. Li J., Rabinovich B.A., Hurren R., Shannon J., and Miller R.G. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B. Int. Immunol. 15 (2003) 411-416
25. Liu J., Morris M.A., Nguyen P., George T.C., Koulich E., Lai W.C., Schatzle J.D., Kumar V., and Bennett M. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. J. Immunol. 164 (2000) 1793-1799
26. Lodoen M.B., and Lanier L.L. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3 (2005) 59-69
27. Lodoen M.B., and Lanier L.L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18 (2006) 391-398
28. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
29. Mesci A., and Carlyle J.R. A rapid and efficient method for the generation and screening of monoclonal antibodies specific for cell surface antigens. J. Immunol. Methods (2007) 10.1016/j.jim.2007.02.007 in press. Published online March 15, 2007
30. Mesci A., Ljutic B., Makrigiannis A.P., and Carlyle J.R. NKR-P1 biology: from prototype to missing self. Immunol. Res. 35 (2006) 13-26
31. Plougastel B., Dubbelde C., and Yokoyama W.M. Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 53 (2001) 209-214
32. Plougastel B., Matsumoto K., Dubbelde C., and Yokoyama W.M. Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics 53 (2001) 592-598
33. Raulet D.H., and Vance R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6 (2006) 520-531
34. Reddehase M.J. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2 (2002) 831-844
35. Reynolds C.W., Bere Jr. E.W., and Ward J.M. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat. J. Immunol. 132 (1984) 534-540
36. Rosen D.B., Bettadapura J., Alsharifi M., Mathew P.A., Warren H.S., and Lanier L.L. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 175 (2005) 7796-7799
37. Sanderson S., and Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6 (1994) 369-376
38. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99 (2002) 8826-8831
39. Vidal S.M., and Lanier L.L. NK cell recognition of mouse cytomegalovirus-infected cells. Curr. Top. Microbiol. Immunol. 298 (2006) 183-206
40. Voigt S., Sandford G.R., Ding L., and Burns W.H. Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus. J. Virol. 75 (2001) 603-611
41. Wills M.R., Ashiru O., Reeves M.B., Okecha G., Trowsdale J., Tomasec P., Wilkinson G.W., Sinclair J., and Sissons J.G. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175 (2005) 7457-7465
42. Yokoyama W.M., and Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3 (2003) 304-316
43. Zhou H., Kartsogiannis V., Hu Y.S., Elliott J., Quinn J.M., McKinstry W.J., Gillespie M.T., and Ng K.W. A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J. Biol. Chem. 276 (2001) 14916-14923